BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6865827)

  • 41. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
    Balkin MS; Buchholtz M; Ortiz J; Green AJ
    Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Granulocytopenia associated with anti-thyroid drugs].
    Matsumoto N; Suetsugu M; Kobayashi K; Abe S; Kageoka T
    Rinsho Ketsueki; 1976 Jan; 17(1):82-7. PubMed ID: 987286
    [No Abstract]   [Full Text] [Related]  

  • 43. [Agranulocytosis with tonsillitis associated with methimazole therapy].
    Zambrana JT; Zambrana FF; Neto FR; Gonçalves AL; Zambrana FF; Ushirohira J
    Braz J Otorhinolaryngol; 2005; 71(3):374-7. PubMed ID: 16446945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris.
    Miyasaka Y; Yoshimura M; Tabata S; Shozu A; Nishikawa M; Iwasaka T; Inada M
    Thyroid; 1997 Aug; 7(4):621-4. PubMed ID: 9292952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rare side effects in management of hyperthyroidism. Case report].
    Sohár G; Kovács M; Györkös A; Gasztonyi B
    Orv Hetil; 2016 May; 157(22):869-72. PubMed ID: 27211356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial thioamide-induced lupus syndrome in thyrotoxicosis.
    Searles RP; Plymate SR; Troup GM
    J Rheumatol; 1981; 8(3):498-500. PubMed ID: 6945435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Case report of mucormycosis in a patient with secondary methimazole-induced agranulocytosis].
    Ramírez C; Hernández AF; Méndez V; Trejo S; Contreras R; Espinosa de los Monteros AL; Gómez LM; Mercado M
    Gac Med Mex; 2009; 145(3):235-8. PubMed ID: 19685830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.
    Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
    Nakamura H; Miyauchi A; Miyawaki N; Imagawa J
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis.
    Vyas AA; Vyas P; Fillipon NL; Vijayakrishnan R; Trivedi N
    Endocr Pract; 2010; 16(4):673-6. PubMed ID: 20439250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis.
    Cho YY; Shon HS; Yoon HD
    Korean J Intern Med; 2005 Dec; 20(4):335-8. PubMed ID: 16491833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral manifestations of agranulocytosis associated with methimazole therapy.
    Hou GL; Tsai CC
    J Periodontol; 1988 Apr; 59(4):244-8. PubMed ID: 3164375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver failure due to antithyroid drugs: report of a case and literature review.
    Livadas S; Xyrafis X; Economou F; Boutzios G; Christou M; Zerva A; Karachalios A; Palioura H; Palimeri S; Diamanti-Kandarakis E
    Endocrine; 2010 Aug; 38(1):24-8. PubMed ID: 20960098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): a case report.
    Chien MN; Wang CH; Tsan KW
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):351-5. PubMed ID: 8605651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Agranulocytosis associated with anti-thyroid drug in patients with Graves' thyrotoxicosis--report of 11 cases.
    Li KL; Huang HS; Wang PW; Lin JD; Juang JH; Liu RT; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1991 Sep; 14(3):168-73. PubMed ID: 1718579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease.
    Rabelo PN; Rabelo PN; Paula AF; Conceição SAD; Viggiano DPPO; Antunes DE; Jatene EM; Paula SLFM; Dias ML; Reis MAL
    Rev Assoc Med Bras (1992); 2019 Jul; 65(6):755-760. PubMed ID: 31340298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudomonas aeruginosa necrotizing fasciitis in a patient with methimazole-induced agranulocytosis.
    Cheng HT; Lin FY
    Am Surg; 2011 Nov; 77(11):1561-2. PubMed ID: 22196675
    [No Abstract]   [Full Text] [Related]  

  • 59. Graves' Disease Thyrotoxicosis and Propylthiouracil Related Agranulocytosis Successfully Treated with Therapeutic Plasma Exchange and G-CSF Followed by Total Thyroidectomy.
    Candoni A; De Marchi F; Vescini F; Mauro S; Rinaldi C; Piemonte M; Rabassi N; Dubbini MV; Fanin R
    Mediterr J Hematol Infect Dis; 2017; 9(1):e2017058. PubMed ID: 29181135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.